Please assess the completion status of the following clinical trial:

Trial Title: Hyperinflation Assessment After Treatment by Lung Volume Reduction Coil

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Severe emphysema (recent CT-scan (\< 6 mois) )~* Age \> 35 ans~* Modified Medical Research Council Scale (mMRC) \> 2~* Forced expiratory volume in one second (FEV1) post-bronchodilatator \< 45%~* Residual volume \> 175%~* Total Pulmonary capacity \> 100%~Exclusion Criteria:~* Forced expiratory volume in one second (FEV1) variability \> 20% after bronchodilatator~* Carbon Monoxide Diffusing Capacity (TLCO) \< 20%~* Recurrent respiratory infection Infections with clinics symptoms~* Pulmonary arterial hypertension (PAH) with Pulmonary Arterial Systolic Pressure (PAPS) estimated with echography \> 50 mm Hg~* Impossibility to walk more that 140 meter (6 min test)~* Surgery history of volume reduction or pulmonary transplantation~* Broncho-dilatation with clinic symptoms

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patient with severe emphysema (Type: OTHER): Patients with severe emphysema, stable, symptomatic, not controlled despite of international recommendations treatments will have bronchoscopy

Based on this trial design, predict the completion outcome and termination type (if applicable).